Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

28.98
Delayed Data
As of Dec 15
 +0.01 / +0.03%
Today’s Change
24.82
Today|||52-Week Range
41.20
+0.49%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.5B

Company Description

ACADIA Pharmaceuticals, Inc. engages in the research, development and manufacture of pharmaceutical products. It focuses on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Contact Information

ACADIA Pharmaceuticals, Inc.
3611 Valley Centre Drive
San Diego California 92130-3331
P:(858) 558-2871
Investor Relations:

Employees

Shareholders

Mutual fund holders55.97%
Other institutional42.32%
Individual stakeholders30.35%

Top Executives

Stephen R. DavisPresident, Chief Executive Officer & Director
James A. NashSenior VP-Technology Development & Operations
Todd S. YoungExecutive VP, Chief Financial & Accounting Officer
Srdjan R. StankovicExecutive VP, Head-Research & Development
James OwenChief Medical Officer & SVP-Clinical Development